The American Urological Association (AUA) and Società Italiana di Urologia (SIU) have collaborated to develop an independent educational activity to review the latest updates in immuno-oncology. This one hour course is designed to improve clinicians’ understanding of current immunotherapeutic agents for the treatment of GU cancers, improve patient outcomes, and the management of adverse events. The course covers the following topics:

Immuno-Oncology: A Focus on Kidney Cancer

Immuno-Oncology: A Focus on Bladder Cancer

Immuno-Oncology: A Focus on Prostate Cancer

Managing Immune-Related Adverse Events

ACKNOWLEDGEMENTS

Independent educational grant support for the webcast and podcast provided by Merck & Co., Inc., Kenilworth, NJ, US

CME Available:

https://auau.auanet.org/content/therapeutic-advances-immuno-oncology-2019